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FluorescenceInitiation is the rate-limiting step during mRNA 50 cap-dependent translation, and thus a target of a
strict control in the eukaryotic cell. It is shown here by analytical ultracentrifugation and ﬂuores-
cence spectroscopy that the afﬁnity of the human translation inhibitor, eIF4E-binding protein
(4E-BP1), to the translation initiation factor 4E is signiﬁcantly higher when eIF4E is bound to the
cap. The 4E-BP1 binding stabilizes the active eIF4E conformation and, on the other hand, can facil-
itate dissociation of eIF4E from the cap. These ﬁndings reveal the particular allosteric effects form-
ing a thermodynamic cycle for the cooperative regulation of the translation initiation inhibition.
Structured summary of protein interactions:
4E-BP1 and eIF4E bind by cosedimentation in solution (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The central player in eukaryotic cap-dependent translation is
the heterotrimeric eIF4F complex [1], responsible for recruitment
of the small ribosomal subunit 40S. eIF4F is composed of the mul-
tifunctional eIF4G protein, the DEAD-box RNA helicase eIF4A and
highly conserved eIF4E which is a primary anchor to the mRNA
50 cap structure [2] (Scheme 1). This speciﬁc binding is a rate-
limiting step for translation initiation [3]. eIF4G forms a bridge
between eIF4E and the ribosome through other initiation factors
and gives rise to mRNA circularization via an interaction with the
poly(A)-binding proteins.The eIF4E–eIF4G interface is a target of regulation by inhibitory
proteins, 4E-BPs [4], that share a common eIF4E-binding motif
with eIF4Gs [5]. Crystal structures of ternary complexes of eIF4E,
a cap analogue, and the eIF4GII or 4E-BP1 peptide fragment
revealed that both peptides bind eIF4E in the same manner, at
the opposite side of eIF4E in relation to the cap-binding slot [6]
(Scheme 1B). After mTOR-dependent hyperphosphorylation,
4E-BPs are no longer able to bind eIF4E [7] and the translation
initiation can proceed [8].
eIF4E is overexpressed in tumour cells and its suppression
inhibits the malignant transformation, thus targeting eIF4E may
be promising in anti-cancer therapy [9]. Rational drug design
aimed at eIF4E requires analysis of intermolecular interactions,
including equilibrium association constants, Kas, which comple-
ment the static structural description of the crystal complexes,
and provide us with the understanding of the protein dynamical
behaviour in solution.
4E-BP1 is a natively disordered protein that partially folds upon
association with eIF4E [10,11] which is, in turn, highly unstable in
the apo-form [12–14]. This makes biophysical analyses of the
interactions that rule the 4E-BP1/eIF4E/cap ternary complex non-
OO
N
+
N O
OHOH
OPOP
OO
O O
OP
O
O
ON
N
CH3O
NH2
OH
H
mRNA
B
(A)
(B)
(C)
Scheme 1. (A) Scheme of the fragment of the translation preinitiation complex. Inhibitory activity of 4E-BP1 is marked as the red arrow. (B) Ternary complex of eIF4E (gold),
m7GpppA as the mRNA 50 cap analogue (blue) and a fragment of 4E-BP1 (red) (1wkw [21]). (C) Chemical structure of the cap.
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must be taken into account.
Experimental data related to the inﬂuence of the cap on eIF4G
and 4E-BP1 binding are scarce due to difﬁculty of working with
apo-eIF4E. Our previous studies showed that the eIF4G/4E-BP1
binding site of eIF4E is more densely ordered when the protein is
complexed with m7GTP [15], in agreement with the NMR dynam-
ics study [16]. We also revealed a 1.6-fold increase of eIF4GI(569–
580) peptide afﬁnity to cap-saturated eIF4E in comparison with the
apo-protein, while no cooperativity was observed for 4E-BP1(51–
67) that interacted with both eIF4E forms similarly, with Kas of
107 M1 [12].
Conversely, the inﬂuence of eIF4G or 4E-BP1 on the eIF4E cap
binding was more extensively elaborated. The pioneering SPR
studies, accompanied by afﬁnity column capacity measurements,were interpreted in terms of the eIF4E cap-afﬁnity enhancement
by 4E-BP1 [17]. The unambiguous eIF4E–cap complex stabilization
was shown for larger fragments of eIF4G [18]. Accordingly, we re-
ported a slightly higher association constants for m7GTP binding by
eIF4E saturated with eIF4GI and eIF4GII peptides, while, again, no
cooperativity could be detected for 4E-BP1(51–67) [12].
Another open issue is related to the eIF4E-afﬁnity for the 4E-BPs
shorter fragments vs. the full-length proteins, since a direct com-
parison of the results obtained in solution and by surface-based
methods, such as SPR, could be eligible only after satisfying strict
SPR requirements within models providing for conformational
changes [19]. Otherwise, such comparison could yield incoherent
conclusions, especially that even the afﬁnity values for the same
complex formation and obtained within the same SPR protocol
could differ thousands of times [20–25] (Supplementary Table).
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Fig. 1. Sedimentation velocity analysis of eIF4E–4E-BP1 interaction. Sedimentation
coefﬁcient distribution c(s) of 4.3 lM apo-eIF4E (—), 87 lM apo-4E-BP1 (––), and
the mixture of 4.3 lM eIF4E with 4E-BP1 at 0.5 lM (---), 4.5 lM ( ), and
45 lM ( ). Inset: the weighted-average s-values (sw) derived from integration
of c(s) as a function of 4E-BP1 concentration (d) and the best ﬁt of the 1:1 hetero-
association isotherm (—).
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within the binary and ternary complexes of human full-length 4E-
BP1 with eIF4E and the mRNA 50 cap analogue. We apply analytical
ultracentrifugation, both sedimentation velocity and equilibrium
experiments, with rigorous ﬂuorescence titration analysis [26] to
elucidate intricate cooperative effects in the inhibited eIF4E–cap
complex.
2. Materials and methods
m7GTP was synthesised as described previously [27]. The
concentration was determined spectrophotometrically on Jasco
V-650 or Carry 100 Bio (Varian) spectrophotometers.
Human full-length eIF4E was expressed and puriﬁed as
described earlier [28]. The ﬁnal step was ion-exchange chromatog-
raphy to remove misfolded molecules and aggregates (Supplemen-
tary Fig. 1). Gel ﬁltration proved the eIF4E monomeric state
(Supplementary Fig. 2). The samples were ﬁltered through
0.45 lm syringe ﬁlters with FVDF membrane (ROTH). Total con-
centration of eIF4E was determined from absorption, e280
52940 cm1M1 calculated using ProtParam [29].
Full-length 4E-BP1 was expressed in Escherichia coli BL21 (DE3)
cells as the GST-fusion protein from the pGEX-6p1_h4E-BP1 plas-
mid, and puriﬁed using Glutathione Sepharose 4B bed (GE Health-
care) and Vydac C8 semi-preparative HPLC RP column as described
in Supplementary Methods. 4E-BP1 concentration was determined
from absorption, e280 2980 cm1M1 [29].
Analytical ultracentrifugation was run at 20 C on Beckman
Optima XL-I with 8-position An-Ti rotor and UV detection at
280 nm in a double-sector 1.2 cm cells with charcoal-ﬁlled epon
centrepieces and sapphire windows.
Sedimentation velocity experiments were performed at
50000 rpm. Radial absorption scans of protein concentration pro-
ﬁles were measured at 8-min intervals. Proteins were dialyzed
twice against DB (50 mM HEPES/KOH buffer pH 7.2, 100 mM KCl
and 0.1 mM TCEP), and 400 ll of the dialysate was loaded into ref-
erence sectors. Samples (390 ll) contained eIF4E at 4.3 lM, 4E-BP1
at 87 lM, or their mixtures containing 4E-BP1 at 0.5 lM to 45 lM.
The solution of m7GTP in DB was added to the suitable protein
mixtures and to the reference to the ﬁnal concentration of 5 lM.
The sedimentation velocity data were analysed using program
SEDFIT with a continuous sedimentation coefﬁcient distribution
model, c(s), based on the Lamm equation [30,31]. To get the asso-
ciation constant for the eIF4E–4E-BP1 interaction, the c(s) distribu-
tions were integrated to provide the weighted-average
sedimentation coefﬁcients as a function of 4E-BP1 concentration
(sw isotherm) [32]. The data was analysed by ﬁtting 1:1 hetero-
association model to the binding isotherm using SEDPHAT pro-
gram [33]. For more details see Supplementary methods.
Sedimentation equilibrium experiments were performed at
21000 rpm or for the multispeed experiments at 20000, 25000,
and 30000 rpm. Samples (110 ll) at the same concentrations as
that for the velocity sedimentation experiments, and DB (120 ll)
were placed in the cells. The radial concentration gradient was
collected 10 times every 4 h at intervals of 0.001 cm, until the sed-
imentation equilibrium was attained (30 h). The data were ana-
lysed by non-linear regression using SEDPHAT program,
according to 1:1 hetero-association model and a global ﬁtting to
all experimental runs at various rotor speeds and eIF4E/4E-BP1
molar ratios [34] (see Supplementary methods).
Partial speciﬁc volumes of eIF4E and 4E-BP1, buffer density and
viscosity were calculated using SEDNTERP program [35].
Fluorescence titrations of eIF4E at 0.15–0.25 lM, 20 C, in
50 mM HEPES/KOH pH 7.2, 100 mM KCl, 1 mM dithiothreitol and
0.5 mM disodium ethylenediaminetetraacetate were performed
as described previously [12,26] on Fluorolog Tau-3 (Horiba JobinYvon), in a thermostated quartz semi-micro cell (Hellma) with
the optical length of 4/10 mm for excitation/emission, respectively.
Aliquots of 1 ll m7GTP at increasing concentrations, 2 lM to 1 mM,
were added to 1400 ll of eIF4E. Excitation/emission wavelengths
of 280/337 nm and 295/340 nm were applied with 1/4 nm spectral
resolution and 4 s integration time. The excitation shutter was
closed between measurements to avoid photobleaching. The
ﬂuorescence intensities were corrected for the inner ﬁlter effect,
dilution and background, and analysed as a function of the total li-
gand concentration by non-linear, least-squares regression, using
ORIGINPro 8 (Microcal Software Inc). Association constants, Kas,
and concentrations of active eIF4E, Pact, were obtained as described
previously [26,36]. Statistical analysis was done on the basis of
runs tests and goodness of ﬁt R2 > 0.99.
3. Results and discussion
Since analytical ultracentrifugation is the method of choice to
get reliable protein–protein binding constants without any cova-
lent modiﬁcations of interacting species [37], we performed inde-
pendent sedimentation velocity (Fig. 1) and sedimentation
equilibrium (Fig. 2) experiments. Both types of the ultracentrifuga-
tion experiments could be performed for the interactions of eIF4E
only with the full length 4E-BP1 and not with the short 4E-BP1
peptides, since the difference in sedimentation velocity and equi-
librium for complexes with the latter and eIF4E alone are below
the limit of detection.
Firstly, Kas determined by both methods for full-length 4E-BP1
binding to apo-eIF4E are in a perfect agreement (Table 1), and
are very close (within 3r) to the value for the short 4E-BP1(51–
67) peptide, 10  106 M1, obtained earlier by another highly
reproducible, in-solution, equilibrium method, i.e., titration based
on intrinsic ﬂuorescence quenching of unmodiﬁed protein upon
complex formation [7]. These suggest that the N- and C-terminal
4E-BP1 tails ﬂanking the eIF4E-binding site do not play a role in
recognition of apo-eIF4E. This observation is consistent with the
NMR [10] and SAXS [11] data that showed partial folding and com-
paction of the 4E-BP1 central region containing the eIF4E-binding
motif upon interaction with apo-eIF4E.
In contrast, while we did not observe any afﬁnity changes of
eIF4E to the 4E-BP1 short peptide after previous saturation of eIF4E
with the mRNA 50 cap analogue (Kas 10  106 M1) [12], a signif-
icant, about 10-fold increase of the association constant for the
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Fig. 2. Upper panels: sedimentation equilibrium gradients for mixtures containing 5 lM m7GTP, 4.3 lM eIF4E, and 4E-BP1 at 0.6 lM (A), 7.5 lM (B), and 24 lM (C), for the
rotor speeds of 20000 (o), 25000 (d), and 30000 rpm ( ) with the best global ﬁts (—) of 1:1 hetero-association model. Bottom panels: ﬁtting residuals.
Table 1
Equilibrium association constants, Kas, and binding free energies, DG, at 20 C for
formation of binary and ternary complexes of eIF4E with 4E-BP1 and the mRNA 50 cap
analogue, m7GTP.
Titrating ligand Preincubated ligand Kas (lM1) DG [kcal/mol]
Analytical ultracentrifugation
4E-BP1 m7GTP (lM)
Sedimentation velocity experiments
0
5
6.18 ± 1.28
58 ± 15
–9.10 ± 0.12
–10.41 ± 0.15
Sedimentation equilibrium experiments
0 6.34 ± 0.87 –9.12 ± 0.08
5 52 ± 14 –10.35 ± 0.16
Fluorescence titration a
m7GTP 4E-BP1 (lM)
0
0.06
0.18
0.60
1.48
1.80
107.3 ± 5.0
89.1 ± 7.0
73.8 ± 2.9
60.3 ± 3.2
43.0 ± 3.9
56.5 ± 3.1
10.77 ± 0.03
10.66 ± 0.05
10.55 ± 0.02
10.44 ± 0.03
10.23 ± 0.05
10.40 ± 0.03
a Fluorescence titrations of eIF4E at 0.17 lM with m7GTP in the absence and
presence of increasing concentrations of 4E-BP1.
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length 4E-BP1 (Table 1). This corresponds to the complex stabiliza-
tion stronger by about 1.2 kcal/mol, which is a typical value of
one non-covalent contact in water milieu. This enhanced interac-
tion shows that full-length 4E-BP1 can detect the eIF4E conforma-
tional changes upon the cap binding, which conﬁrms the previous
studies that revealed the structural basis for the positive allosteric
effect [15,16,38].
Functional signiﬁcance of the N- and C-terminal 4E-BPs parts
ﬂanking the eIF4E-binding site was analysed earlier by binding
studies for full-length 4E-BPs and their shorter fragments [24,25].
The data from which the conclusions were drawn varied signiﬁ-
cantly not only according to the applied method but also within
the same approach (Supplementary Table). Our results show
clearly that the N- and C-terminal 4E-BP1 regions play important
role in formation of the complex with eIF4E only when the trans-
lation factor is already bound to the mRNA 50 cap, but not in the
case of the apo-eIF4E.For small ligands binding, ﬂuorescence titration was proved to
be the most exact approach [12,26,36]. To our surprise, the precise
values of the equilibrium association constants that we obtained
for the cap binding to eIF4E after prior incubation with increasing
concentrations of 4E-BP1 showed unambiguously that 4E-BP1 re-
duces the eIF4E-m7GTP binding constant by 50% (Fig. 3, Table 1).
Apparently, this seems contradictory to the former results regard-
ing greater amounts of eIF4E retained on the cap-afﬁnity column in
the presence of 4E-BPs [17]. However, this twofold decrease of Kas,
at the high afﬁnity of 108 M1, corresponds to weakening of the
complex stability by 0.37 kcal/mol, i.e., only 60% of the thermal
energy, a negligible difference as for the m7GTP-Sepharose afﬁnity
assay. Thus, the effect observed by us could not be revealed in the
previous bed- and surface-supported experiments [17]. In fact,
those greater quantities of eIF4E eluted from the cap-afﬁnity col-
umn when bond to 4E-BP1 [17] could reﬂect the differences in
the eIF4E fractions, i.e. the active fraction capable of interacting
with the afﬁnity bed. Earlier studies showed that 4E-BP1 stabilized
the eIF4E structure by preventing proteolysis [13] and crystalliza-
tion facilitation [39,40]. We have analysed quantitatively [26,36]
the inﬂuence of 4E-BP1 on the active eIF4E concentration in the
sample. Fig. 3D shows the clear and systematic increase of the ac-
tive eIF4E fraction (i.e., capable of binding to the mRNA 50 cap),
from 40% to 93%, depending on the 4E-BP1 to eIF4E molar ratio
in the identical eIF4E samples at a total concentration of 0.17 lM.
The plateau is approached at the threefold excess of 4E-BP1, which
corresponds to 94% saturation of eIF4E by 4E-BP1 in the presence
of m7GTP. This marked conformational stabilization effect exerted
by 4E-BP1 on eIF4E is in agreement with the recent structural NMR
ﬁndings that 4E-BP1 transforms eIF4E into a state, which is more
susceptible for cap-binding [38] and with the conformational
changes revealed earlier for the yeast eIF4E in the complex with
the eIF4G fragment [41]. The over twofold increase of the active
eIF4E concentration (Fig. 3D) resolves the apparent contradiction
with McCarthy’s group [17], since, statistically, over twice more
eIF4E molecules can interact with the mRNA 50 cap in the presence
of 4E-BP1. Thus, naturally, more amount of eIF4E could be then re-
tained on the m7GTP-Sepharose [17].
Allosteric effects on the eIF4E-cap binding, common for full-
length 4E-BP1 and eIF4G fragments, were also anticipated from
the comparison of the X-ray diffraction and NMR data [38]. How-
ever, those suppositions were based only on, sometimes self-con-
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Fig. 3. eIF4E afﬁnity to mRNA 50 cap is down-regulated by 4E-BP1. (A) Binding
isotherms from ﬂuorescence titrations for interaction of m7GTP with eIF4E at
0.15 lM in the apo-form (d), and in the presence of 1.5 lM 4E-BP1 (o), with the
corresponding ﬁtting residuals. The arrow points that saturation of apo-eIF4E with
the cap occurs at lower concentrations than of eIF4E with 4E-BP1. (B) Control: pure
buffer (d) and 1.5 lM 4E-BP1 (o) titrated with m7GTP, proving that no interaction
occurs between 4E-BP1 and m7GTP. (C) Dependence of the eIF4E-m7GTP association
constant, Kas, and (D) of the amount of the active eIF4E, Pact, on the 4E-BP1/eIF4E
molar ratio, with Boltzmann sigmoidal curve (—) and 95% conﬁdence interval
( ).
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methodological approach. While the mutually positive allosteric
effect of the yeast eIF4G or its fragments on the eIF4E–capassociation was well documented [18,42,43], the human eIF4E-
cap interaction was surprisingly shown to be unaffected by the
presence or absence of the eIF4E-binding domain of eIF4G and vice
versa [44].
Moreover, modulation of the eIF4E biological activity by 4E-BPs
and eIF4Gs can be variant, despite the local secondary structure
similarity of their eIF4E-bound short helical fragments [6]. It was
shown previously that the image of interactions within ternary
complexes including eIF4E, 4E-BP1 or eIF4G short peptides, and a
cap analogue was unsymmetrical [12], since binding of one ligand
inﬂuenced the eIF4E afﬁnity to the other, but this was not neces-
sarily accompanied by the evident effect in the reverse direction.
Here, we have revealed an intricate cooperativity between the
two eIF4E binding sites. The cumulative Gibbs free energy of the
eIF4E binding to the cap and then to 4E-BP1 equals
21.15 ± 0.12 kcal/mol, while the binding constants describing
the ternary complex formation in the reverse order lead to the va-
lue of DG = 19.51 ± 0.08 kcal/mol (Table 1, Scheme 2). Since the
Gibbs free energy difference between this two pathways exceeds
three standard deviations, this could suggest that another internal
equilibrium process related to a conformational rearrangement of
the eIF4E/4E-BP1 complex upon the cap binding might take place
that is neither reﬂected by measurable intrinsic ﬂuorescence
changes nor by ultracentrifugation. This process would be related
to DG of 1.64 kcal/mol (which is 3 kT; thermal energy at
20 C) and correspond to the conformational equilibrium constant,
Keq of 16.7. This relatively low value means that more that 5% of
the ternary complex population could be present as the less stable
(eIF4E/4E-BP) cap intermediate (Scheme 2). The results can be
interpreted as a kind of a thermodynamic cycle, as follows: the
mRNA 50 cap binding makes the afﬁnity of eIF4E to full length
4E-BP1 signiﬁcantly stronger, and then the binding of 4E-BP1 to
the cap/eIF4E complex makes the cap dissociation slightly easier,
since the association constant for the cap binding to eIF4E/4E-BP
is twice lower than to eIF4E alone.
Our results thus support the opposite functions of the transla-
tion repressors and the translation initiation factors, since it ap-
pears that translation could be additionally inhibited by 4E-BP1
via facilitation of eIF4E dissociation from the mRNA 50 cap in the
living cell within a kind of a negative feedback loop.
It was interesting to consider the possibility of competition be-
tween the full length 4E-BP1 (118 residues) and the eIF4E-binding
domain of eIF4G (90 residues) to eIF4E. The afﬁnity of the eIF4G
fragment to eIF4E was determined by SPR in the low nanomolar
range, both for the human [44] and yeast [41] proteins. The equi-
librium association constant for the human eIF4G–eIF4E complex,
ca. 230  106 M1 [44], is 35-fold greater than for the binding of
4E-BP1 to apo-eIF4E and still fourfold greater than in the case of
the cap-bound eIF4E (Table 1). Bearing in mind that surface-based
measurements may not always be compared directly to the equi-
librium solution studies, one may cautiously conclude that the
afﬁnity of 4E-BP1 to eIF4E in the complex with the mRNA 50 cap
approaches to the strength of the eIF4E–eIF4G interaction.
The 4E-BP repressors are important mediators of mTORC1 reg-
ulatory function in cell growth and proliferation [45]. Most of the
former investigations were focused on eIF4E afﬁnity regulation
by multiple 4E-BP phosphorylations, but the mechanism of trans-
lation inhibition by non-phosphorylated 4E-BPs can also be inﬂu-
enced by cooperativity between the cap- and eIF4G/4E-BP-
binding sites. Based on the consistent quantitative studies, we have
demonstrated for the ﬁrst time that eIF4E bound to the mRNA 50
cap comes under more strict control by full length 4E-BP1, which
is accomplished by blocking the eIF4G-binding site with the asso-
ciation constant by one order of magnitude greater than that for
apo-eIF4E. We have also explained that the biophysical origin of
the observed 4E-BP1 inﬂuence on the eIF4E–cap binding is related
eIF4E Kas ~100 · 106 [M -1]
ΔG°  -10.8 [kcal/mol] 
Kas ~50 · 106 [M -1]
ΔG°  -10.4 [kcal/mol] 
4E-BP1/eIF4E eIF4E/cap
(4E-BP1/eIF4E)
cap
4E-BP1/eIF4E/cap 
Keq ~17 
ΔG°   -1.6 [kcal/mol] 
Kas ~6 · 106 [M -1]
ΔG°  -9.1 [kcal/mol] 
Kas ~50 · 106 [M -1]
ΔG°  -10.4 [kcal/mol] 
Scheme 2. Cap–eIF4E–4E-BP1 binding thermodynamic cycle.
A. Modrak-Wojcik et al. / FEBS Letters 587 (2013) 3928–3934 3933to stabilization of the proper eIF4E conformation, accompanied by
a slight decrease of the eIF4E–cap association constant.
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